|
|
|
|
||
PADUFA date 10/15Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy https://finance.yahoo.com/news/avadel-pharmaceuticals-announces-fda-acceptance-130000954.html |
return to message board, top of board |